手法复位联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕的疗效分析

详细信息    查看全文 | 推荐本文 |

英文篇名：Analysis on treatment of benign paroxysmal positional vertigo with manual reduction combined with betastatin mesylate tablets 作者：沈友进 ; 王丹 ; 万婷玉 ; 任庆华 ; 王艳竹 ; 李孟修 英文作者：SHEN Youjin;WANG Dan;WAN Tingyu;REN Qinghua;WANG Yanzhu;LI Mengxiu;Department of Neurology,Jiangmen People's Hospital; 关键词：良性阵发性位置性眩晕 ; 手法复位 ; 甲磺酸倍他司汀 ; 临床观察 英文关键词：Benign paroxysmal positional vertigo;;Manual reset;;Betastatin mesylate;;Clinical observation 中文刊名：GYKX 英文刊名：China Medicine and Pharmacy 机构：广东省江门市人民医院神经内科; 出版日期：2019-02-15 出版单位：中国医药科学 年：2019 期：v.9;No.195 语种：中文; 页：GYKX201903056 页数：3 CN：03 ISSN：11-6006/R 分类号：200-202

摘要

目的手法复位联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕的治疗效果。方法选取2017年6月～2018年6月我院收治的良性阵发性位置性眩晕患者58例,随机分为观察组和对照组两组。对照组患者根据患者临床症状采取相应手法复位,观察组患者在手法复位的基础上联合使用甲磺酸倍他司汀片进行治疗,治疗7d为1个疗程,对两组患者治疗1、6个月的复发情况、Berg平衡量表(BBS)评分、前庭症状指数(VSI)、计时平衡实验结果及治疗效果进行比较。结果观察组患者复发率明显低于对照组,症状和功能改善明显优于对照组,总有效率明显高于对照组,差异有统计学意义(P <0.05)。结论手法复位联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕可以提高治疗效果,值得在临床推广。
        Objective To discuss the treatment effect of benign paroxysmal positional vertigo with manual reduction combined with betastatin mesylate tablets. Methods Fifty-eight patients with benign paroxysmal positional vertigo admitted to our hospital during June 2017 to June 2018 were randomly divided into an observation group and a control group.The patients in the control group were treated by manipulative reduction according to their clinical symptoms,and the patients in the observation group were treated by combined use of betastatin mesylate tablets on the basis of manipulative reduction,and 7 days was a course of treatment.Relapse,score of BBS,VSI,timing balance experiment results and treatment effect were compared between the two groups at 1 and 6 months after treatment.Results The recurrence rate of patients in the observation group was significantly lower than that in the control group,the improvement of symptoms and functions was significantly better than that in the control group,and the total effective rate was significantly higher than that in the control group,the differences were statistically significant(P < 0.05). Conclusion Manipulative reduction combined with betastastine mesylate in the treatment of benign paroxysmal positional vertigo can improve the therapeutic effect and is worthy of clinical promotion.

引文

[1]杨璐瑜,许建梅.Epley手法复位配合甲磺酸倍他司汀片治疗后半规管良性阵发性位置性眩晕的临床观察[J].陕西医学杂志,2017,46(8):1089-1090.
    [2]廖传明,刘艳萍,廖华英.强力定眩片联合甲磺酸倍他司汀片治疗后循环缺血性眩晕疗效观察[J].四川中医,2016,34(2):213-214.
    [3]李会娟.甲磺酸倍他司汀片联合手法复位治疗良性阵发性位置性眩晕效果分析[J].河南医学研究,2017,26(22):4113-4114.
    [4]许旭琴.手法复位联合甲磺酸倍他司汀片治疗耳石症患者的临床观察[J].山西医药杂志,2018,47(8):900-902.
    [5]武婷.自制眩晕贴穴位贴敷治疗耳石症手法复位后眩晕38例[J].中国中医药科技,2017,24(4):517-518.
    [6]许明.手法复位联合甲磺酸倍他司汀片治疗耳石症患者的临床观察[J].医疗装备,2017,30(13):4-5.
    [7]严杰,李艳玲,褚小燕,等.手法复位联合倍他司汀治疗良性阵发性位置性眩晕的临床研究[J].中国药物与临床,2015,15(5):664-665.
    [8]邓蔚霖.手法复位联合甲磺酸倍他司汀治疗耳石症临床观察[J].中国医学科学,2018,8(1):217-218.
    [9]王凯,荣良群,朱本亮,等.Epley手法复位联合眩晕宁治疗青年后半规管良性阵发性位置性眩晕效果观察[J].中国综合临床,2015,31(9):795-798.
    [10]郭敏,江超武,李书聆,等.手法复位配合甲磺酸倍他司汀治疗老年良性阵发性位置性眩晕效果分析[J].中国医学创新,2015,12(36):126-129.
    [11]杨钱红,姜玉龙,陈林,等.口服甲磺酸倍他司汀片及改变睡姿减少耳石症复发的临床研究[J].海南医学,2015,26(24):3640-3642.
    [12]李进让,张昊,郭鹏飞.快速手法复位治疗多半规管良性阵发性位置性眩晕的近远期疗效分析[J].中国耳鼻咽喉颅底外科杂志,2015,21(3):191-194.
    [13]舒竞铖,尹时华,刘渊,等.手法复位联合中药治疗良性阵发性位置性眩晕临床研究文献的Meta分析[J].世界中医药,2015,10(4):598-605.
    [14]李建兴,周华磊,卢永田.良性阵发性位置性眩晕手法复位短期疗效不佳患者的临床特征分析[].中国医药科学,2017,7(6):135-137.
    [15]潘晓峰,刘红梅.手法复位联合个性化前庭康复训练治疗良性阵发性位置性眩晕的疗效[J].中国康复,2015,30(5):368-369.
    [16]郭丽君.手法复位联合甘露醇、盐酸倍他司汀治疗良性阵发性位置性眩晕效果观察[J].山东医药,2015,55(12):41-42.